Pharmaceutical composition for the treatment of genetically caus

Details Pharmaceutical composition for the treatment of genetically caus Pharmaceutical composition for the treatment of genetically caus

1988-02-12

1990-07-24

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514912, A61K 3150

Patent

active

049435752

ABSTRACT:
The present invention relates to the use of pteridines and/or biochemical precursors thereof or xanthinoxidase inhibitors for the treatment of genetically caused degenerative retina diseases, in particular retinopathia pigmentosa (RP), and a pharmaceutical composition containing the same.

REFERENCES:
patent: 4425344 (1984-01-01), Horlington
patent: 4425345 (1984-01-01), Horlington et al.
patent: 4425346 (1982-01-01), Horlington et al.
patent: 4746668 (1988-05-01), Sato et al.
Ann. Optamol. Clin. Ocul., 97:143-153 (1971).

Affiliated with

Also associated with

Rating

Pharmaceutical composition for the treatment of genetically caus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for the treatment of genetically caus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for the treatment of genetically caus will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1267908